0000000000130094

AUTHOR

Antonina Stagno

showing 8 related works from this author

AMINO-HETEROCYCLES AS SYNTHONS FOR THE SYNTHESIS OF POTENTIAL ANTICANCER AGENTS

2009

AMINO-HETEROCYCLESSettore CHIM/08 - Chimica Farmaceutica
researchProduct

INDOLO[2,3-B]PYRROLYZIN-8(1H)ONE: A NEW RING SYSTEM WITH POTENTIAL ANTIMITOTIC ACTIVITY

2009

INDOLO[23-B]PYRROLYZIN-8(1H)ONESettore CHIM/08 - Chimica Farmaceutica
researchProduct

Pyrido[4′,3′:4,5]pyrrolo[2,1-d][1,2,3,5]tetrazines, a new class of Temozolomide heteroanalogues

2009

A series of derivatives of new ring system pyrido[4’,3’:4,5]pyrrolo[2,1-d] [1,2,3,5]tetrazine was obtained from moderate to excellent yields by reaction of 2-diazo-3-ethoxycarbonyl-pyrrolo[2,3- c]pyridine with alkyl- or aryl-isocyanates in dichlorometane at room temperature or at 50 °C under microwave irradiation.

Temozolomide heteroanaloguesOrganic ChemistrySettore CHIM/08 - Chimica FarmaceuticaArkivoc
researchProduct

Synthesis of the new ring system pyrrolizino[2,3-b]indol-4(5H)-one

2011

Derivatives of the new ring system pyrrolizino[2,3-b]indol-4(5H)-one were prepared in four steps starting from substituted benzonitriles bearing a functionalized amino group in the adjacent position. The unsubstituted- and the dimethoxy-pyrrolizinoindolones 5a and 5b exhibited modest activity against the HL-60(TB) human leukemia cell line, whereas the N-methylated dimethoxy-pyrrolizinoindolone 6b showed to be selective against MOLT-4 leukemia, A549/ATCC, HOP-92, and NCI-H460 non-small cell lung cancer, and CAKI-1 renal cancer cell lines.

NitrileStereochemistryOrganic ChemistryCancerBiological activityRing (chemistry)medicine.diseaseSettore CHIM/08 - Chimica FarmaceuticaBiochemistryChemical synthesisPyrrolizino[2; 3-b]indol-4(5H)-one Tripentone Antitumor activity Antitubulin agentsPyrrolizino[23-b]indol-4(5H)-one Tripentone Antitumor activity Antitubulin agentschemistry.chemical_compoundLeukemia3-b]indol-4(5H)-one Tripentone Antitumor activity Antitubulin agentschemistryCell cultureDrug DiscoveryPyrrolizino[2medicineSelectivity
researchProduct

ChemInform Abstract: Synthesis of the New Ring System Pyrrolizino[2,3-b]indol-4(5H)-one.

2011

A variety of pyrrolizinoindolones (VIII) is synthesized as demonstrated for derivative (VIIIa).

chemistry.chemical_compoundchemistryStereochemistryGeneral MedicineRing (chemistry)Derivative (chemistry)ChemInform
researchProduct

Synthesis of Triazenoazaindoles: a New Class of Triazenes with Antitumor Activity

2011

Despite improvements in the treatment and prevention of cancer, the number of new diagnoses continues to rise; this has fuelled substantial interest in the development of new and effective chemotherapeutic agents. Compounds of the triazene class, such as dacarbazine, have been used in the clinical management of many cancer types including brain, leukemia, and melanoma. A new compound class bearing a triazenoazaindole scaffold was synthesized with the aim of identifying new antiproliferative agents. Compounds 5 a-g and 6 a-c were screened against a panel of human tumor cell lines, and two of them, 5 e and 5 f, showed cytotoxicity (GI(50) range: 2.2-8.2 μM) in all cell lines. These two compou…

Programmed cell deathIndolesToxicology and Pharmaceutics (all)DacarbazineAntineoplastic AgentsAntiproliferative activityPharmacologyEGF receptorsDrug Screening AssaysBiochemistryCell LineFlow cytometryCell Line TumorNeoplasmsDrug DiscoveryTriazenoazaindolemedicineHumansTriazeno derivativesGeneral Pharmacology Toxicology and PharmaceuticsCytotoxicityPharmacologyAntitumor agentsTumorEpidermal Growth Factormedicine.diagnostic_testChemistryMelanomaOrganic ChemistryCancerAntitumorTriazenoazaindoles; Dacarbazine; Antitumor Activitymedicine.diseaseErbB ReceptorsDacarbazineApoptosisCell cultureMolecular MedicineDrug Screening Assays AntitumorAntitumor ActivityTriazenesTriazenoazaindolesAntiproliferative activity; Antitumor agents; EGF receptors; Triazeno derivatives; Antineoplastic Agents; Cell Line Tumor; Dacarbazine; Drug Screening Assays Antitumor; Humans; Indoles; Neoplasms; Receptor Epidermal Growth Factor; Triazenes; Pharmacology Toxicology and Pharmaceutics (all); Organic Chemistry; Molecular MedicineReceptormedicine.drugChemMedChem
researchProduct

Pyrido[2’,3’:4,5]pyrrolo[2,1-d][1,2,3,5]tetrazine-4(3H)-ones, a new class of temozolomide heteroanalogues

2009

Twelve derivatives of new ring system pyrido[2’,3’:4,5]pyrrolo[2,1-d][1,2,3,5]tetrazine were prepared in good yields by reaction of 2-diazo-3-ethoxycarbonyl-pyrrolo[3,2-b]pyridine with alkyl- or aryl-isocyanates. Nine derivatives, screened by the National Cancer Institute (Bethesda, MD) for the in vitro one dose primary anticancer assay against a panel of about 60 human tumor cell lines, showed no significant activity.

3Stereochemistry21-d][1Temozolomide Mitozolomide; pyrrolo[2; 1-d][1; 2; 3; 5]tetrazinones; Antitumor activity; pyrido[2’; 3’:4; 5]pyrrolo[2; 1-d][1; 2; 3; 5]tetrazinesTemozolomide MitozolomideRing (chemistry)Medicinal chemistryD-1Tetrazinechemistry.chemical_compoundpyrido[2’PyridineAlkylchemistry.chemical_classification5]tetrazinonesOrganic Chemistrypyrrolo[23’:4Antitumor activity pyrido[2’3’:45]pyrrolo[21-d][1235]tetrazinesSettore CHIM/08 - Chimica Farmaceuticachemistry5]pyrrolo[2Microwave irradiationTemozolomide Mitozolomide pyrrolo[21-d][1235]tetrazinoneAntitumor activity5]tetrazinesArkivoc
researchProduct

4-AZAINDOLE[2,1-D][1,3,5]TETRAZINE-4(3H)-ONES, A NEW CLASS OF AZOLOTETRAZINES AS POTENTIAL ANTITUMOR AGENTS

2008

AZOLOTETRAZINESSettore CHIM/08 - Chimica Farmaceutica
researchProduct